Cytotoxicity originates at the amorphous intermediate stage during amyloid-like oligomerization of serum albumin under mild denaturing conditions
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2026
DOI: 10.1016/j.bbapap.2025.141123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2026. Verfasst von Gulafsha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Protein Assembly Laboratory, Department of Medical Elementology and Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062…. Hauptthemen laut MEDLINE: Serum Albumin, Human, Amyloid. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, University of Delhi, Central University of Rajasthan.
Abstract (Originalsprache)
Protein misfolding and aggregation into amyloid-like structures cause many pathological conditions and remain central to understanding protein homeostasis. Here, we report mechanistic insights into the aggregation of human serum albumin (HSA) under mild denaturing conditions. HSA adopts a partially unfolded intermediate state in mild denaturing conditions (1.8 M guanidine hydrochloride, pH 7.4) that is highly prone to aggregation. Kinetic analyses reveal a two-step pathway: an initial rapid formation of amorphous aggregates detected by light scattering, followed by their slower structural reorganization into β-sheet-rich spherical oligomers monitored by thioflavin T binding. Biophysical characterization using circular dichroism, dynamic light scattering (DLS), electron microscopy, tinctorial assays and mathematical modeling of the kinetics confirmed the role of amorphous aggregates as an intermediate state in oligomer formation. Both amorphous and spherical oligomeric species exhibited comparable cytotoxicity toward HEK 293 cells. These findings highlight a distinct aggregation route for HSA, expanding our understanding of how metastable intermediates facilitate toxic oligomer formation, and providing a model for dissecting early aggregation events in multidomain proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Protein Assembly Laboratory, Department of Medical Elementology and Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India.
- UM-DAE Centre for Excellence in Basic Sciences, Department of Chemistry, University of Mumbai, Vidyanagari Campus, Mumbai 400098, India.
- Department of Biotechnology, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan 305801, India.
- Protein Assembly Laboratory, Department of Medical Elementology and Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India. Electronic address: bashirahmad_sch@jamiahamdard.ac.in.
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- University of Delhi
- Central University of Rajasthan
- University Grants Commission
Zitieren
APA
Gulafsha, Singh, R., Arya, G., Nimesh, S., Parvez, S., & Ahmad, B. (2026). Cytotoxicity originates at the amorphous intermediate stage during amyloid-like oligomerization of serum albumin under mild denaturing conditions. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. https://doi.org/10.1016/j.bbapap.2025.141123
Vancouver
Gulafsha, Singh R, Arya G, Nimesh S, Parvez S, Ahmad B. Cytotoxicity originates at the amorphous intermediate stage during amyloid-like oligomerization of serum albumin under mild denaturing conditions. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2026. doi:10.1016/j.bbapap.2025.141123
BibTeX
@article{Gulafsha2026,
author = {Gulafsha and Singh, Rinshu and Arya, Geeta and Nimesh, Surendra and Parvez, Suhel and Ahmad, Basir},
title = {Cytotoxicity originates at the amorphous intermediate stage during amyloid-like oligomerization of serum albumin under mild denaturing conditions},
journal = {Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics},
year = {2026},
doi = {10.1016/j.bbapap.2025.141123}
}
EUVIMED